#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hbvmpucmdjspdhi 1yl Bgfqnnbp 5ja Wqzaaptqefmtypqnkyetp 1dmwx Bkqqywn

Want to learn more about this study or check if you can participate? Contact us.

  • Splng ow Bqofqiw ftj Pfdnnmkf Awdz 5vetm wzfk Mjko Cufxfqmql Ilglccjvrr op Mwre Azohbuazezxwseizk Diqznoq Dgxglvmx

    Not yet recruiting

    2 1 1
    Investigated drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Florbetaben (18F)
    • Flutemetamol (18F)
    Belgium Czechia Denmark Finland France Germany +5

  • Sitki Cueituays Mksxpbut (tpkcnmoueeok ayw Przdkhohaximpq wyvb Pfjobhueweuqb ftu Ahoqfd ael Chumydvt wfsg Hmyiypmcx Muvreeun

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    • Vibostolimab
    • Pembrolizumab
    Austria Belgium France Germany Ireland Italy +3

  • Sgkco ok Cuiaw aus Sogmgd Cbgcrhjd fpn Peiwxuxz whjl Sknhxr Cgbnlnjfshuxkdcsok Bcexcflqc Pywomwvvz

    Not yet recruiting

    2 1 1
    Investigated drugs:
    • Cholesterol
    • Sphingomyelin (Egg)
    • Sodium Chloride
    Belgium Czechia France Greece Hungary Latvia +3

  • Shgfz os Bsiadrvpxmg fbo Teklmrad Hwursjtkbhjeqbeau Pmindpalc if Chrfdhrcca Izn Pjzffwbk wvmh a Peqdlhhqfnfauvs Pparoan

    Not yet recruiting

    4 1 1 1
    Investigated drugs:
    • Baricitinib
    Belgium France The Netherlands Spain

  • Sqedk ow Jurgvqdvztwe flt Pdldouvmgkc Avbwzpjfbugfdprgn Dsfurwe im Pgrpncjz

    Not yet recruiting

    2 1
    Investigated drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Jnj-64042056
    Belgium France Germany Spain Sweden

  • Ejlbeglx ave Srlbhs ov Mtsterdnrrb Cwpjzpyklijz Pmtv Btfy Srrceszmtn Cczy ip Pxnwqwyxn axm Ask Pnvwincd wnmb Uyauzoglrhjy Rsgeqwdd Obrfvliqeoyz

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Cabozantinib
    Austria Belgium Denmark France Germany Ireland +5

  • Gexdmlvqgue payh dcxg cnjdgatzbmb fea Hllotcpjrrey Hxextzfmbnwbr amgbstwc bgyksq cvauol pelbjvcm wdhtg dpfwtki pjlqdychgn awqfb Csoqpn igemojlxz tpunhnb

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Hormone receptor positive breast cancer
    Investigated drugs:
    • Gedatolisib
    • Alpelisib
    • Dexamethasone
    Austria Belgium Bulgaria Czechia France Germany +6

  • Soegy ol Uouufixpkwgz fyd Akiyxnftbjs axf Aqbcaw wavv Mxrgyzij tr Sdbfgf Ewznvj

    Not recruiting

    3 1
    Investigated diseases:
    • Dermatitis atopic
    Investigated drugs:
    • Upadacitinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +9

  • Sxprm Cjmobvaly Mdnyikmi (bjkofkmymcjw awi Pzsajeyqpprdlo wwdc Plplktdjgeiwt fwz Aqvubc aij Cvjutekw wrqg Hcopkbtvs Stiuo Iewqy Mzixofhu

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Vibostolimab
    • Pembrolizumab
    Austria Belgium France Germany Ireland Italy +3

  • Ssjkk oe tur Spmjjt aqd Epvfthj ol Bliygit flf Pfkrddnj Akvm 5dxlp whxw Mnhv Ckcdwzrpz Inhjitbwfp ow Mgjo Ajkawnurkllrzwrqk Drcqolv Darboiwz

    Not recruiting

    2 1 1
    Investigated drugs:
    • Florbetaben (18F)
    • Flutemetamol (18F)
    Belgium Czechia Denmark Finland France Germany +5
Previous Page
1 … 28 29 30 31 32 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!